| 000 | 01900 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516080422.0 | ||
| 264 | 0 | _c20120720 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1873-7544 | ||
| 024 | 7 |
_a10.1016/j.neuroscience.2012.02.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGillardon, F | |
| 245 | 0 | 0 |
_aParkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity. _h[electronic resource] |
| 260 |
_bNeuroscience _cApr 2012 |
||
| 300 |
_a41-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aChemokines _xmetabolism |
| 650 | 0 | 4 | _aCulture Media, Conditioned |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aInflammation _xgenetics |
| 650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
| 650 | 0 | 4 | _aLeucine-Rich Repeat Serine-Threonine Protein Kinase-2 |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aMacrophage Activation _xphysiology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aMicroglia _xmetabolism |
| 650 | 0 | 4 |
_aMutation _xphysiology |
| 650 | 0 | 4 |
_aNeurons _xphysiology |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xgenetics |
| 650 | 0 | 4 |
_aParkinson Disease _xgenetics |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aToll-Like Receptor 4 _xbiosynthesis |
| 700 | 1 | _aSchmid, R | |
| 700 | 1 | _aDraheim, H | |
| 773 | 0 |
_tNeuroscience _gvol. 208 _gp. 41-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuroscience.2012.02.001 _zAvailable from publisher's website |
| 999 |
_c21553307 _d21553307 |
||